reement with Hempmate Zurich AG for further expansion into the European CBD market. France Medical cannabis has been legal in France since 2013 and Marinol has been the only product prescribed. In 2018, the ANSM launched an investigation to explore scientific data for therapeutic uses of the plants, type

lecules. Of the three types, phytocannabinoids have garnered a lot of interest because of their therapeutic and recreational potential. For example, Marinol and Syndros, which the FDA cleared for the treatment of anorexia associated with weight loss in AIDS patients, include the active ingredient dronabin

synthetic biology and biocatalysis. For example, a synthetic version of THC known as dronabinol is the active compound in the pharmaceutical product Marinol, which was approved by the FDA in 1985 for use in treatment of nausea and vomiting associated with cancer chemotherapy. Methods for biosynthetic prod